Capsule Summary Slidesets


Share

Program Content

Activities

  • HPTN 083: Results in TGW
    HPTN 083: Safety, Efficacy, and Gender-Affirming Hormonal Therapy Interactions With Long-Acting Injectable CAB for HIV PrEP in Transgender Women
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 01, 2022

    Expires: July 31, 2023

    View Activity
  • NAMSAL Wk 192 Results
    NAMSAL: Wk 192 Results of Dolutegravir-Based vs Low-Dose Efavirenz-Based Regimens as First-line ART in Cameroon
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 02, 2022

    Expires: August 01, 2023

    View Activity
  • SIMPL’HIV Wk 144
    SIMPL’HIV Wk 144 Results: Dolutegravir + Emtricitabine vs Standard Combination ART for Maintenance of Virologic Suppression
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 02, 2022

    Expires: August 01, 2023

    View Activity
  • ALLIANCE Study Results
    ALLIANCE: Phase III Randomized Controlled Trial of BIC/FTC/TAF vs DTG + FTC/TDF in Treatment-Naive Adults With HIV/HBV Coinfection
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 03, 2022

    Expires: August 02, 2023

    View Activity
  • HPTN 084: CAB in Cisgender Women
    HPTN 084 Update: Long-Acting Injectable CAB vs Daily Oral TDF/FTC for HIV PrEP in Cisgender Women
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 03, 2022

    Expires: August 02, 2023

    View Activity
  • TB-PRACTECAL
    TB-PRACTECAL: Efficacy and Safety of Three 24-Wk Oral Regimens for Pulmonary Rifampicin-Resistant TB in Persons With HIV
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 04, 2022

    Expires: August 03, 2023

    View Activity
  • DoxyPEP: Doxycycline STI PEP
    DoxyPEP: Prevention of STIs With Doxycycline PEP Among MSM and TGW With HIV or Receiving PrEP
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 04, 2022

    Expires: August 03, 2023

    View Activity
  • 6-Mo PrEP + HIVST
    Effect of 6-Mo PrEP Dispensing Plus HIV Self-Testing on 12-Mo PrEP Continuation
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 05, 2022

    Expires: August 04, 2023

    View Activity
  • VRC01 in Infants
    IMPAACT 2008: Broadly Neutralizing Antibody VRC01 Plus ART in Infants With HIV
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 05, 2022

    Expires: August 04, 2023

    View Activity
  • ANDES
    ANDES: Generic Fixed-Dose DRV/RTV in Combination With 3TC vs 3TC/TDF for Initial HIV Treatment
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 05, 2022

    Expires: August 04, 2023

    View Activity

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner